Abstract
Since the introduction of Chiari’s concept of “tryptic autodigestion” of the pancreatic gland in 1869 [7], several pancreatic enzymes have been implicated as triggers of acute pancreatitis. However, the initiating factor(s) has still not been clarified. Many of the pancreatic enzymes have been suggested. Activated proteases, such as trypsin [5, 10] and elastase [33, 36], have been found in complex with protease inhibitors in both blood and peritoneal fluid [24, 25]. The probable role of granulocyte proteases has also been emphasized [6, 20]. All these findings indicate liberation of active proteases during the disease. In addition, some studies have shown activation of the different cascade systems of the body, such as the complement, kinin, coagulation and fibrinolytic systems. A similar activation has also been shown in other conditions in which active proteases are set free, for example, sepsis [26, 31], abscesses [17], burns [17] and multiple trauma [17, 19]. The clinical importance of these biochemical events and of their interrelation is, as yet, not fully understood.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Balldin G (1980) On protease-antiprotease imbalance with special reference to the protective role of protease inhibitors in acute pancreatitis. Thesis, Malmö
Balldin G, Eddeland A, Ohlsson K (1981) Studies on the role of the plasma protease inhibitors on C3-activation in vitro and in acute pancreatitis. Scand J Gastroenterol 16:603–609
Balldin G, Ohlsson K (1979) Demonstration of pancreatic protease-antiprotease complexes in the peritoneal fluid of patients with acute pancreatitis. Surgery 85:451–456
Barrett AJ, Starkey PM (1973) The interaction of alpha-2-macroglobulin with proteinases. Biochem J 133:709–724
Borgström A, Ohlsson K (1978) Immunoreactive trypsin in serum and peritoneal fluid in acute pancreatitis. Hoppe Seylers Z Physiol Chem 359:677 — 681
Brower MS, Harpel PC (1982) Proteolytic cleavage and inactivation of alpha-2-plasmin inhibitor and Cl-inactivator by human polymorphonuclear leucocyte elastase. J Biol Chem 257:9849–9854
Chiari H (1896) Über die Selbstverdauung des menschlichen Pankreas. Z Heilkd 17:69–96
Creutzfeldt W, Schmidt H (1970) Aetiology and pathogenesis of pancreatitis (current concepts). Scand J Gastroenterol [Suppl] 6:47 — 62
Dürr HK (1979) Acute pancreatitis. In: Howat HT, Sarles H (eds) The exocrine pancreas. Saunders, London
Elias E, Redshaw M, Wood T (1977) The diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet 2:66–68
Freise J (1983) Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine. Enzyme 30:209
Freise J, Melzer P, Schmidt FW, Horbach L (1986) Gabexat Mesilat in der Behandlung der akuten Pankreatitis. Ergebnisse der Hannoverschen multizentrischen Doppelblindstudie mit 50 Patienten. Z Gastroenterol 24:200–211
Freise J, Schmidt FW (1984) Gabexat Mesilat (FOY) in der Behandlung der akuten Pankreatitis. Z Gastroenterol 22:531 (Abstract)
Fritz H, Krück J (1979) Immunofluorescence studies indicate that the basic trypsin-kal-likrein-inhibitor of bovine organs (Trasylol) originates from mast cells. Hoppe Seylers Z Physiol Chem 360:437–444
Fritz H, Oppitz KH, Meckl D, Kemkes B, Haendle H, Schult H, Werle E (1969) Verteilung und Ausscheidung von natürlich vorkommenden und chemisch modifizierten Proteaseinhibitoren nach intravenöser Injektion bei Ratte, Hund (und Mensch). Hoppe Seylers Z Physiol Chem 350:1541–1550
Geokas MC, Largman C, Durie PR, Brodrick JW, Ray SB, O’Rourke M, Vollmer J (1981) Immunoreactive forms of cationic trypsin in plasma and ascites fluid of dogs in experimental pancreatitis. Am J Pathol 105:31–39
Heideman M, Saravis C, Clowes GHA (1982) Effect of nonviable tissue and abscesses on complement depletion and the development of bacteremia. J Trauma 22:527–532
Kazal LA, Spicer DS, Brahinsky RA (1948) Isolation of a crystalline trypsin inhibitor. J Am Chem Soc 70:3034–3040
Kierulf P, Aasen AO, Aune S, Godai MC, Ruud TE, Vaage J (1982) Chromogenic peptide substrate assays in patients with multiple trauma. Acta Chir Scand [Suppl] 509:69–72
Klingemann HG, Egbring R, Holst F, Gramse M, Havemann K (1981) Digestion of alpha-2-plasmin inhibitor by neutral proteases from human leucocytes. Thromb Res 24:479–483
Kraut H, Frey EK, Werle E (1930) Über die Inaktivierung des Kallikreins. Hoppe Seylers Z Physiol Chem 192:1–21
Kunitz M, Northrop JH (1936) Isolation from beef pancreas of crystalline trypsinogen, trypsin, a trypsin inhibitor, and an inhibitor-trypsin compound. J Gen Physiol 19:991–1007
Lake-Bakaar G, McKavanagh S, Gatus B, Summerfleld JA (1980) The relative values of serum immuno-reactive trypsin concentration and total amylase activity in the diagnosis of mumps, chronic renal failure, and pancreatic disease. Scand J Gastroenterol 15:97–101
Lasson A, Ohlsson K (1984) Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course. Scand J Gastroenterol 19:779–786
Lasson A, Ohlsson K (1984) Acute pancreatitis. The correlation between clinical course, protease inhibitors, and complement and kinin activation. Scand J Gastroenterol 19:707–710
McConn R, Wasserman F, Haberland G (1982) The role of chemical mediators in the pathophysiology of acute illness and injury. Raven, New York
McMahon MJ, Bowen M, Mayer AD, Cooper EH (1984) Relation of alpha-2-macro-globulin and other antiproteases to the clinical features of acute pancreatitis. Am J Surg 147:164–170
Nevalainen TJ (1980) The role of phospholipase A in acute pancreatitis. Scand J Gastroenterol 15:641–650
O’Connor CM, O’Donnell MD, McGeeney KF (1981) Problems associated with the radioimmunoassay of serum trypsin. Clin Chim Acta 114:29–35
Opie EL (1901) The etiology of acute hemorrhagic pancreatitis. Bull Johns Hopk Hosp 12:182–188
Smith-Erichsen N, Aasen AO, Amundsen E (1982) Treatment of sepsis in the surgical patient evaluated by means of chromogenic peptide substrate assays. Acta Chir Scand [Suppl] 509:33–38
Tanaka N, Tsuchiya R, Ishii K (1979) Comparative clinical study of FOY and Trasylol in acute pancreatitis. In: Fuji S, Meriva H, Suzuki T (eds) Kinins II: systemic proteases and cellular function. Plenum, New York
Toki N, Takasugi S, Sumi H (1982) Isolation and characterization of a pancreatic elastase from plasma of patients with acute pancreatitis. Clin Sei 62:321–328
Vincent JP, Lazdunski M (1976) Pre-existence of the active site in zymogens, the interaction of trypsinogen with the basic pancreatic trypsin inhibitor (Kunitz). FEBS Lett 63:240–244
Vogel R, Trautschold I, Werle E (1966) Natural protease inhibitors — biochemistry and clinical aspects. Thieme, Stuttgart
Wellborn JC, Alston JD, Cannon DJ, Read RC (1983) Serum proteolytic and antiproteolytic activity in acute pancreatitis. Am J Surg 146:834–837
Wendt P, Fritsch A, Schulz F, Wunderlich G, Blümel G (1984) Proteinases and inhibitors in plasma and peritoneal exudate in acute pancreatitis. Hepatogastroenterology 31:277–281
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Singer, M.V., Goebell, H. (1987). Antiproteases: Effective Treatment with Gabexate Mesilate. In: Beger, H.G., Büchler, M. (eds) Acute Pancreatitis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83027-3_37
Download citation
DOI: https://doi.org/10.1007/978-3-642-83027-3_37
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83029-7
Online ISBN: 978-3-642-83027-3
eBook Packages: Springer Book Archive